Table 1.
Baseline data tables on clinicopathological factors and the presence or absence of TLS in patients
| Yes TLS | No TLS | p-value | |
|---|---|---|---|
| Patient | 57(100%) | 26(100%) | - |
| Recrudescence | 0.685 | ||
| Yes | 6(10.5%) | 2(7.7%) | |
| No | 51(89.5%) | 24(92.3%) | |
| T123 | 0.900 | ||
| T1 | 16(29.6%) | 6(25%) | |
| T2 | 20(37%) | 9(37.5%) | |
| T3 | 18(33.3%) | 9(37.5%) | |
| T12/T34 | 0.635 | ||
| T1/T2 | 36(63.2%) | 15(57.7%) | |
| T3/T4 | 21(36.8%) | 11(42.3%) | |
| N123/N0 | 0.436 | ||
| N1N2N3 | 17(29.8%) | 10(38.5%) | |
| N0 | 40(70.2%) | 16(61.5%) | |
| N side | 0.663 | ||
| Single side | 7(12.3%) | 5(19.2%) | |
| Both side | 10(17.5%) | 5(19.2%) | |
| Neither side | 40(70.2%) | 16(61.6%) | |
| M | 0.409 | ||
| M1 | 2(3.6%) | 2(7.6%) | |
| M0 | 55(96.4%) | 24(92.4%) | |
| Tumor volume(cm3) | 0.552 | ||
| < 71.9 | 43(75.4%) | 18(69.2%) | |
| ≥ 71.9 | 14(24.6%) | 8(30.8%) | |
| Corpus cavernosum penis | 0.231 | ||
| Yes | 27(47.4%) | 16(61.5%) | |
| No | 30(52.6%) | 10(38.5%) | |
| Corpus cavernosum urethra | 0.403 | ||
| Yes | 34(59.6%) | 18(69.2%) | |
| No | 23(40.4%) | 8(30.8%) | |
| Inguinal lymph nodes | 0.344 | ||
| Yes | 16(28.1%) | 10(38.5%) | |
| No | 41(71.9%) | 16(61.5%) | |
| Grade I/II or III/IV | 0.692 | ||
| I/II | 39(68.4%) | 15(57.7%) | |
| III/IV | 18(31.6%) | 11(42.3%) | |
| Scope of operation | 0.726 | ||
| Total excision | 12(21.4%) | 6(25%) | |
| Part excision | 44(78.6%) | 18(75%) | |
| Chemotherapy | 0.941 | ||
| Yes | 18(31.6%) | 8(30.8%) | |
| No | 39(68.4%) | 18(69.2%) | |
| PT(s) | 0.449 | ||
| < 11.85 | 30(52.6%) | 16(61.5%) | |
| ≥ 11.85 | 27(47.4%) | 10(38.5%) | |
| APTT(s) | 0.046 | ||
| < 28.55 | 26(45.6%) | 18(69.2%) | |
| ≥ 28.55 | 31(54.4%) | 8(30.8%) | |
| D-dimer(mg/L FEU) | 0.034 | ||
| < 0.5 | 33(61.1%) | 8(34..8%) | |
| ≥ 0.5 | 21(38.9%) | 15(65.2%) | |
| Life cycle (month) | 31(10-72) | 56.5(27.0-84.0) | 0.018 |
| Squamous cell associated antigen(μg /L) | 1.24(0.74-3.72) | 3.8(1.31-13.75) | 0.049 |
| Cytokeratin(ng/ml) | 1.96(1.31-2.46) | 2.38(1.81-3.59) | 0.116 |
| Age | 51.98 ± 11.2 | 55.15 ± 14.8 | 0.283 |
| CEA | 1.85(1.21-2.85) | 2.16(1.39-4.72) | 0.226 |
| CA125 | 9.30(7.2-13.3) | 10.90(7.2-17.5) | 0.471 |
| CA199 | 4.40(3.0-11.2) | 5.35(1.35-7.59) | 0.497 |
The data are expressed as n(%) and median (interquartile), with median (M) describing the mean of the data and interquartile (IQR) describing the degree of dispersion. TNM stage, Grade 2017AJCC penile cancer